Drugs / Bioseal
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03110783 | Sep 2017 → Sep 2019 | benign neoplasm, cancer, vascular malformation | Guangzhou Bioseal Biotechnology Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bioseal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03110783 ↗ |
| Route | Topical | “a thin layer will be applied to the entire length of the suture line and the adjacent area to approximately 5mm away, including all suture holes” NCT03110783 ↗ |